*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Institut/NNP Merieux/NNP S.A./NNP ]
raised/VBD 
[ the/DT stakes/NNS ]
in/IN 
[ a/DT bidding/NN war/NN ]
for/IN 
[ Connaught/NNP BioSciences/NNPS Inc./NNP ]
with/IN 
[ a/DT plan/NN ]
to/TO offer/VB 
[ 37/CD Canadian/JJ dollars/NNS ]
 (/( 
[ US$/$ 31.31/CD ]
 )/) for/IN 
[ each/DT Connaught/NNP ]
share/NN 
[ it/PRP ]
does/VBZ n't/RB already/RB 
[ own/JJ ]
,/, giving/VBG 
[ the/DT company/NN ]

[ an/DT indicated/VBN value/NN ]
of/IN 
[ C$/$ 942/CD million/CD ]
 (/( 
[ US$/$ 797/CD million/CD ]
 )/) ./. 

======================================

[ The/DT offer/NN ]
will/MD replace/VB 
[ a/DT proposal/NN ]
made/VBN by/IN 
[ Merieux/NNP last/JJ March/NNP ]
to/TO combine/VB 
[ its/PRP$ human/JJ health/NN businesses/NNS ]
with/IN 
[ that/DT ]
of/IN 
[ Connaught/NNP ]
,/, 
[ a/DT Toronto-based/JJ vaccine/NN manufacturer/NN ]
./. 

[ That/DT plan/NN ]
would/MD have/VB left/VBN 
[ Connaught/NNP shareholders/NNS ]
with/IN about/IN 
[ 49/CD %/NN ]
of/IN 
[ the/DT merged/JJ company/NN ]
,/, 
[ Merieux/NNP Connaught/NNP N.V./NNP ]
,/, and/CC drew/VBD 
[ criticism/NN ]
from/IN 
[ shareholders/NNS ]
and/CC 
[ analysts/NNS ]
,/, 
[ who/WP ]
said/VBD 
[ it/PRP ]
was/VBD difficult/JJ to/TO 
[ value/VB ]
./. 

======================================

Earlier/RBR 
[ this/DT month/NN ]
,/, 
[ a/DT rival/JJ bid/NN ]
emerged/VBD in/IN 
[ the/DT shape/NN ]
of/IN 
[ a/DT joint/JJ C$/$ 30-a-share/JJ offer/NN ]
for/IN 
[ all/DT ]
of/IN 
[ Connaught/NN 's/POS shares/NNS ]
by/IN 
[ Ciba-Geigy/NNP Ltd./NNP ]
,/, 
[ the/DT Basel/NNP ]
,/, 
[ Switzerland/NNP ]
,/, 
[ pharmaceutical/JJ concern/NN ]
,/, and/CC 
[ Chiron/NNP Corp./NNP ]
,/, 
[ a/DT biotechnology/NN company/NN ]
based/VBN in/IN 
[ Emeryville/NNP ]
,/, 
[ Calif/NNP ]
./. 

======================================

After/IN 
[ a/DT weekend/NN board/NN meeting/NN ]
,/, 
[ Connaught/NNP directors/NNS ]
recommended/VBD 
[ shareholders/NNS ]
reject/VB 
[ the/DT Ciba-Geigy\/JJ offer/NN ]
,/, and/CC unanimously/RB approved/VBD 
[ the/DT terms/NNS ]
of/IN 
[ the/DT proposed/VBN Merieux/NNP bid/NN ]
./. 

[ The/DT bid/NN ]
was/VBD not/RB publicly/RB disclosed/VBN until/IN 
[ yesterday/NN morning/NN ]
./. 

======================================

[ Connaught/NNP 's/POS chairman/NN ]
and/CC 
[ chief/JJ executive/NN officer/NN ]
,/, 
[ Brian/NNP King/NNP ]
,/, said/VBD 
[ the/DT Merieux/NNP cash/NN offer/NN ]
was/VBD 
[ the/DT French/JJ company/NN 's/POS idea/NN ]
,/, but/CC that/IN 
[ the/DT precise/JJ terms/NNS ]
are/VBP 
[ the/DT outcome/NN ]
of/IN ``/`` 
[ negotiations/NNS ]
and/CC 
[ discussions/NNS ]
''/'' over/IN 
[ the/DT weekend/NN ]
./. 

======================================

``/`` Obviously/RB ,/, 
[ there/EX ]
was/VBD 
[ some/DT skepticism/NN ]
about/IN 
[ the/DT short-term/JJ value/NN ]
of/IN 
[ a/DT merged/JJ Merieux-Connaught/NNP ]
,/, ''/'' 
[ Mr./NNP King/NNP ]
said/VBD ,/, referring/VBG to/TO 
[ the/DT earlier/JJR Merieux/NNP merger/NN proposal/NN ]
./. 

In/IN 
[ contrast/NN ]
,/, 
[ he/PRP ]
said/VBD ,/, 
[ the/DT market/NN ]
reacted/VBD favorably/RB to/TO 
[ Ciba-Geigy/NNP 's/POS ]
and/CC 
[ Chiron/NNP 's/POS joint/JJ cash/NN offer/NN ]
./. 

======================================

Following/VBG 
[ the/DT announcement/NN ]
of/IN 
[ the/DT Merieux/NNP bid/NN ]
,/, 
[ Connaught/NNP shares/NNS ]
jumped/VBD in/IN 
[ active/JJ ]
trading/NN on/IN 
[ the/DT Toronto/NNP Stock/NNP Exchange/NNP ]
to/TO close/VB at/IN 
[ C$/$ 37.25/CD ]
 (/( 
[ US$/$ 31.53/CD ]
 )/) ,/, up/RB 
[ C$/$ 3.375/CD ]
./. 

In/IN 
[ national/JJ over-the-counter/JJ ]
trading/NN in/IN 
[ the/DT U.S./NNP ]
,/, 
[ the/DT shares/NNS ]
closed/VBD at/IN 
[ $/$ 31.75/CD ]
,/, up/RB 
[ $/$ 3.125/CD ]
./. 

[ Several/JJ analysts/NNS ]
said/VBD 
[ investors/NNS ]
expect/VBP 
[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP ]
to/TO sweeten/VB 
[ their/PRP$ offer/NN ]
for/IN 
[ Connaught/NNP ]
,/, or/CC for/IN 
[ a/DT third/JJ bid/NN ]
to/TO emerge/VB ./. 

======================================

``/`` 
[ People/NNS ]
are/VBP trying/VBG to/TO figure/VB out/RP 
[ what/WP ]

[ Ciba-Geigy/NNP 's/POS upper/JJ limit/NN ]
is/VBZ ,/, ''/'' said/VBD 
[ Avi/NNP Dalfen/NNP ]
,/, 
[ a/DT Toronto-based/JJ analyst/NN ]
with/IN 
[ Levesque/NNP Beaubien/NNP Geoffrion/NNP Inc/NNP ]
./. 

======================================

[ Ciba-Geigy/NNP ]
is/VBZ interested/JJ in/IN acquiring/VBG 
[ the/DT company/NN ]
to/TO gain/VB 
[ a/DT foothold/NN ]
in/IN 
[ the/DT vaccines/NNS business/NN ]
,/, while/IN 
[ Chiron/NNP ]
appears/VBZ most/RBS interested/JJ in/IN 
[ Connaught/NNP 's/POS production/NN ]
and/CC 
[ marketing/NN capacity/NN ]
,/, 
[ Mr./NNP Dalfen/NNP ]
said/VBD ./. 

======================================

``/`` 
[ The/DT question/NN ]
is/VBZ :/: Is/VBZ 
[ the/DT company/NN worth/NN ]
as/RB much/JJ to/TO 
[ Ciba-Geigy/NNP ]
as/IN 
[ it/PRP ]
is/VBZ to/TO 
[ Merieux/NNP ]
?/. ,/, ''/'' 
[ which/WDT ]
is/VBZ trying/VBG to/TO develop/VB 
[ a/DT critical/JJ mass/NN ]
in/IN 
[ the/DT ]
increasingly/RB 
[ competitive/JJ biotechnology/NN market/NN ]
,/, 
[ Mr./NNP Dalfen/NNP ]
added/VBD ./. 

======================================

[ A/DT spokesman/NN ]
for/IN 
[ Ciba-Geigy/NNP ]
and/CC 
[ Chiron/NNP ]
in/IN 
[ Toronto/NNP ]
said/VBD 
[ the/DT two/CD companies/NNS ]
would/MD review/VB 
[ their/PRP$ options/NNS ]
after/IN 
[ Merieux/NNP 's/POS offering/NN circular/NN ]
is/VBZ mailed/VBN to/TO 
[ shareholders/NNS ]
later/RBR 
[ this/DT week/NN ]
./. 

======================================

``/`` 
[ We/PRP ]
've/VBP made/VBN 
[ a/DT very/RB good/JJ ]
offer/NN ,/, considering/VBG 
[ the/DT synergies/NNS we/PRP ]
have/VBP 
[ that/DT other/JJ ]
 (/( 
[ companies/NNS ]
 )/) do/VBP n't/RB have/VB ,/, ''/'' said/VBD 
[ Jacques-Francois/NNP Martin/NNP ]
,/, 
[ director/NN general/NN ]
of/IN 
[ Institut/NNP Merieux/NNP ]
./. 

======================================

[ Mr./NNP Martin/NNP ]
said/VBD 
[ the/DT acquisition/NN ]
of/IN 
[ Connaught/NNP ]
would/MD help/VB resolve/VB 
[ the/DT problem/NN ]
of/IN competing/VBG with/IN 
[ companies/NNS ]

[ that/WDT ]
are/VBP able/JJ to/TO spend/VB 
[ $/$ 100/CD million/CD ]
to/TO 
[ $/$ 200/CD million/CD ]

[ a/DT year/NN ]
on/IN 
[ product/NN development/NN ]
./. 

======================================

``/`` 
[ There/EX ]
is/VBZ 
[ no/DT future/NN ]
for/IN 
[ Connaught/NNP ]
on/IN 
[ its/PRP$ own/JJ ]
./. 

./. 

./. 

 (/( Alone/RB )/) 
[ we/PRP ]
will/MD disappear/VB from/IN 
[ the/DT scientific/JJ world/NN ]
in/IN 
[ a/DT few/JJ years/NNS ]
,/, ''/'' 
[ he/PRP ]
said/VBD ,/, referring/VBG to/TO 
[ each/DT company/NN ]
./. 

======================================

[ The/DT Merieux/NNP offer/NN ]
is/VBZ conditional/JJ on/IN 
[ the/DT French/JJ concern/NN ]
holding/VBG 
[ 50/CD %/NN ]
of/IN 
[ Connaught/NNP 's/POS shares/NNS ]
,/, plus/CC 
[ one/CD ]
,/, at/IN 
[ the/DT time/NN ]

[ the/DT bid/NN ]
expires/VBZ ./. 

======================================

[ Mr./NNP Martin/NNP ]
said/VBD 
[ the/DT acquisition/NN ]
of/IN 
[ Connaught/NNP ]
would/MD be/VB financed/VBN by/IN 
[ a/DT letter/NN ]
of/IN 
[ credit/NN ]
guaranteed/VBN by/IN 
[ Merieux/NNP 's/POS majority/NN shareholder/NN ]
,/, 
[ state-owned/JJ Rhone-Poulenc/NNP SA/NNP ]
,/, 
[ which/WDT ]
will/MD be/VB repaid/VBN with/IN 
[ the/DT proceeds/NNS ]
of/IN 
[ a/DT planned/JJ equity/NN issue/NN ]
./. 

======================================

[ The/DT Connaught/NNP offer/NN ]
is/VBZ 
[ the/DT second/JJ major/JJ transaction/NN ]
in/IN 
[ as/RB many/JJ weeks/NNS ]
for/IN 
[ Rhone-Poulenc/NNP ]
,/, 
[ which/WDT ]
owns/VBZ 
[ 51/CD %/NN ]
of/IN 
[ Institut/NNP Merieux/NNP ]
./. 

[ Last/JJ week/NN ]

[ it/PRP ]
agreed/VBD to/TO buy/VB 
[ a/DT speciality/NN chemicals/NNS unit/NN ]
of/IN 
[ GAF/NNP Corp./NNP ]
of/IN 
[ the/DT U.S./NNP ]
and/CC 
[ the/DT chemicals/NNS subsidiary/NN ]
of/IN 
[ RTZ/NNP Corp./NNP ]
of/IN 
[ Great/NNP Britain/NNP ]
in/IN 
[ separate/JJ transactions/NNS ]
with/IN 
[ a/DT total/JJ value/NN ]
of/IN about/IN 
[ US$/$ 1.3/CD billion/CD ]
./. 
